These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24970889)

  • 21. Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR.
    McKenna SA; Lindhout DA; Shimoike T; Aitken CE; Puglisi JD
    J Mol Biol; 2007 Sep; 372(1):103-13. PubMed ID: 17619024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and requirement of three ribosome binding domains in dsRNA-dependent protein kinase (PKR).
    Wu S; Kumar KU; Kaufman RJ
    Biochemistry; 1998 Sep; 37(39):13816-26. PubMed ID: 9753471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural features of adenovirus 2 virus-associated RNA required for binding to the protein kinase DAI.
    Clarke PA; Pe'ery T; Ma Y; Mathews MB
    Nucleic Acids Res; 1994 Oct; 22(21):4364-74. PubMed ID: 7971266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA.
    Vyas J; Elia A; Clemens MJ
    RNA; 2003 Jul; 9(7):858-70. PubMed ID: 12810919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variola virus E3L Zα domain, but not its Z-DNA binding activity, is required for PKR inhibition.
    Thakur M; Seo EJ; Dever TE
    RNA; 2014 Feb; 20(2):214-27. PubMed ID: 24335187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of binding sites for both dsRBMs of PKR on kinase-activating and kinase-inhibiting RNA ligands.
    Spanggord RJ; Vuyisich M; Beal PA
    Biochemistry; 2002 Apr; 41(14):4511-20. PubMed ID: 11926812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain.
    Taylor DR; Tian B; Romano PR; Hinnebusch AG; Lai MM; Mathews MB
    J Virol; 2001 Feb; 75(3):1265-73. PubMed ID: 11152499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The binding site of the RNA-dependent protein kinase (PKR) on EBER1 RNA from Epstein-Barr virus.
    Vuyisich M; Spanggord RJ; Beal PA
    EMBO Rep; 2002 Jul; 3(7):622-7. PubMed ID: 12101093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specificity of the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR for double-stranded RNA: insights from thermodynamics and small-angle X-ray scattering.
    Patel S; Blose JM; Sokoloski JE; Pollack L; Bevilacqua PC
    Biochemistry; 2012 Nov; 51(46):9312-22. PubMed ID: 23140277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic characterization of the 5'-triphosphate-dependent activation of PKR: lack of 5'-end nucleobase specificity, evidence for a distinct triphosphate binding site, and a critical role for the dsRBD.
    Toroney R; Hull CM; Sokoloski JE; Bevilacqua PC
    RNA; 2012 Oct; 18(10):1862-74. PubMed ID: 22912486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of single-base substitutions in the central domain of virus-associated RNA I on its function.
    Rahman A; Malhotra P; Dhar R; Kewalramani T; Thimmapaya B
    J Virol; 1995 Jul; 69(7):4299-307. PubMed ID: 7769691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the structural integrity of the three-way junction of adenovirus VAI RNA on PKR inhibition.
    Dzananovic E; Astha ; Chojnowski G; Deo S; Booy EP; Padilla-Meier P; McEleney K; Bujnicki JM; Patel TR; McKenna SA
    PLoS One; 2017; 12(10):e0186849. PubMed ID: 29053745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus VA RNAI Blocks ASC Oligomerization and Inhibits NLRP3 Inflammasome Activation.
    Darweesh M; Kamel W; Gavrilin MA; Akusjärvi G; Svensson C
    Front Immunol; 2019; 10():2791. PubMed ID: 31849970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of activation of the double-stranded-RNA-dependent protein kinase, PKR: role of dimerization and cellular localization in the stimulation of PKR phosphorylation of eukaryotic initiation factor-2 (eIF2).
    Vattem KM; Staschke KA; Wek RC
    Eur J Biochem; 2001 Jul; 268(13):3674-84. PubMed ID: 11432733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner.
    Nallagatla SR; Bevilacqua PC
    RNA; 2008 Jun; 14(6):1201-13. PubMed ID: 18426922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza A Virus Virulence Depends on Two Amino Acids in the N-Terminal Domain of Its NS1 Protein To Facilitate Inhibition of the RNA-Dependent Protein Kinase PKR.
    Schierhorn KL; Jolmes F; Bespalowa J; Saenger S; Peteranderl C; Dzieciolowski J; Mielke M; Budt M; Pleschka S; Herrmann A; Herold S; Wolff T
    J Virol; 2017 May; 91(10):. PubMed ID: 28250123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional domains and the antiviral effect of the double-stranded RNA-dependent protein kinase PKR from Paralichthys olivaceus.
    Zhu R; Zhang YB; Zhang QY; Gui JF
    J Virol; 2008 Jul; 82(14):6889-901. PubMed ID: 18448522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of the structure and function of adenovirus virus-associated RNAs.
    Ma Y; Mathews MB
    J Virol; 1993 Nov; 67(11):6605-17. PubMed ID: 8411363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of interferon synthesis by the PKR-inhibitory VA RNAs of adenoviruses.
    Weber F; Wagner V; Kessler N; Haller O
    J Interferon Cytokine Res; 2006 Jan; 26(1):1-7. PubMed ID: 16426142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of small-molecule mediators of the RNA regulation of PKR, the RNA-dependent protein kinase.
    Carlson CB; Spanggord RJ; Beal PA
    Chembiochem; 2002 Sep; 3(9):859-65. PubMed ID: 12210987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.